rs104894484
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM2PP3_StrongPP5
The NM_017882.3(CLN6):c.368G>A(p.Gly123Asp) variant causes a missense change. The variant allele was found at a frequency of 0.00000657 in 152,166 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_017882.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLN6 | NM_017882.3 | c.368G>A | p.Gly123Asp | missense_variant | Exon 4 of 7 | ENST00000249806.11 | NP_060352.1 | |
CLN6 | NM_001411068.1 | c.464G>A | p.Gly155Asp | missense_variant | Exon 4 of 7 | NP_001397997.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLN6 | ENST00000249806.11 | c.368G>A | p.Gly123Asp | missense_variant | Exon 4 of 7 | 1 | NM_017882.3 | ENSP00000249806.5 | ||
ENSG00000260007 | ENST00000562767.2 | c.84-14165G>A | intron_variant | Intron 1 of 2 | 3 | ENSP00000456336.1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152048Hom.: 0 Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74408
ClinVar
Submissions by phenotype
not provided Pathogenic:1Uncertain:1
The CLN6 c.368G>A (p.Gly123Asp) missense variant results in the substitution of glycine at amino acid position 123 with aspartic acid. This variant has been reported in a homozygous state in one individual with neuronal ceroid lipofuscinosis (PMID: 11727201). The c.368G>A variant is reported in the Genome Aggregation Database in one allele at a frequency of 0.000065 in the Latino/Admixed American population (version 3.1.2). Functional studies have demonstrated that the c.368G>A variant protein is localized in the transmembrane domain 3 and can form dimers; however, the protein is unstable and is rapidly degraded (PMID: 20020536). Multiple lines of computational evidence suggest the variant may have a deleterious effect on the gene or gene product. Based on the available evidence, the c.368G>A (p.Gly123Asp) variant is classified as a variant of uncertain significance for neuronal ceroid lipofuscinosis. -
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); Published functional studies demonstrate a damaging effect as this variant leads to rapid degradation of polypeptides (Oresic et al., 2009; Kurze et al., 2010); This variant is associated with the following publications: (PMID: 19440452, 20020536, 15265688, 18811591, 12673792, 11727201) -
Ceroid lipofuscinosis, neuronal, 6A Pathogenic:1
- -
Ceroid lipofuscinosis, neuronal, 6A;C5561927:Ceroid lipofuscinosis, neuronal, 6B (Kufs type) Pathogenic:1
- -
Neuronal ceroid lipofuscinosis Uncertain:1
This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 123 of the CLN6 protein (p.Gly123Asp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with neuronal ceroid lipofuscinosis (PMID: 11727201; Invitae). ClinVar contains an entry for this variant (Variation ID: 4079). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on CLN6 protein function. Experimental studies have shown that this missense change affects CLN6 function (PMID: 18811591, 20020536). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at